Concepedia

Jimmy Royer

JR

Statistics

Publications

6

Citations

307

H-Index

6

Active since

1987

Affiliations

Analysis Group (United States)(Current)

Massachusetts General Hospital

Critical Path Institute

University of Virginia

Harvard University

Jimmy Royer is an author at Analysis Group (United States) specializing in pharmacology, genomics, and bioinformatics.

Publications per year

1987–2022

6

Publications

6

The Value Of Antihypertensive Drugs: A Perspective On Medical Innovation

David Cutler, Genia Long, Ernst R. Berndt et al. · Health Affairs · 2007 · 131 citations

, , +17

Beyond multidrug resistance: Leveraging rare variants with machine and statistical learning models in Mycobacterium tuberculosis resistance prediction

Michael L. Chen, Akshith Doddi, Jimmy Royer et al. · EBioMedicine · 2019 · 108 citations · Full text

, , +13

Deep learning predicts tuberculosis drug resistance status from genome sequencing data

Michael L. Chen, Akshith Doddi, Jimmy Royer et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2018 · 23 citations · Full text

, , +13

Over-Declaration of Standard Essential Patents and Determinants of Essentiality

Marc Van Audenrode, Jimmy Royer, Robin Stitzing · SSRN Electronic Journal · 2017 · 20 citations · Full text

, , +13

Predicting Clinical Remission of Chronic Urticaria Using Random Survival Forests: Machine Learning Applied to Real-World Data

Irina Pivneva, Maria‐Magdalena Balp, Yvonne Geissbühler et al. · Dermatology and Therapy · 2022 · 14 citations · Full text

, , +17

1–5 of 6